<SEC-DOCUMENT>0001104659-20-043354-index.html : 20200406
<SEC-HEADER>0001104659-20-043354.hdr.sgml : 20200406
<ACCEPTANCE-DATETIME>20200406061120
ACCESSION NUMBER:		0001104659-20-043354
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200423
FILED AS OF DATE:		20200406
DATE AS OF CHANGE:		20200406
EFFECTIVENESS DATE:		20200406

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Anchiano Therapeutics Ltd.
		CENTRAL INDEX KEY:			0001534248
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			L3
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38807
		FILM NUMBER:		20775657

	BUSINESS ADDRESS:	
		STREET 1:		5 KIRYAT HAMADA ST
		STREET 2:		PO BOX 45032
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9777401
		BUSINESS PHONE:		972-2-5486555

	MAIL ADDRESS:	
		STREET 1:		5 KIRYAT HAMADA ST
		STREET 2:		PO BOX 45032
		CITY:			JERUSALEM
		STATE:			L3
		ZIP:			9777401

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BioCancell Ltd.
		DATE OF NAME CHANGE:	20111104
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm2014157-2_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: tm2014157-2_def14a.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>lg_anchiano.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: lg_anchiano.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm2014157d2-pc_meeting1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 3 - file: tm2014157d2-pc_meeting1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm2014157d2-pc_meeting2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 4 - file: tm2014157d2-pc_meeting2.jpg

</DOCUMENT>
</SEC-DOCUMENT>